サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1758043

ヘルスケアにおけるブロックチェーンの世界市場

Blockchain in Healthcare

出版日
ページ情報
英文 216 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.63円
ヘルスケアにおけるブロックチェーンの世界市場
出版日: 2025年06月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 216 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ヘルスケアにおけるブロックチェーンの世界市場は2030年までに130億米ドルに達する見込み

2024年に12億米ドルと推定されるヘルスケアにおけるブロックチェーンの世界市場は、2024年から2030年にかけてCAGR 49.0％で成長し、2030年には130億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるプライベートネットワークは、CAGR 51.8％を記録し、分析期間終了までに104億米ドルに達すると予測されます。パブリックネットワークセグメントの成長率は、分析期間でCAGR 40.4％と推定されます。

米国市場は推定3億1,220万米ドル、中国はCAGR 46.2％で成長予測

米国のヘルスケアにおけるブロックチェーン市場は、2024年に3億1,220万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに19億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは46.2％となります。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ44.9％と41.9％と予測されています。欧州では、ドイツがCAGR約33.2%で成長すると予測されています。

世界のヘルスケアにおけるブロックチェーン市場- 主要動向と促進要因のまとめ

なぜブロックチェーンがヘルスケアイノベーションの基盤技術として台頭しているのか？

ブロックチェーン技術はヘルスケアにおける変革の力として急速に受け入れられており、データの断片化、セキュリティの脆弱性、管理プロセスの非効率性など、ヘルスケア業界で最も根強い課題に対処することが期待されています。ブロックチェーンは、その中核において、多様なヘルスケア利害関係者間で安全かつ透明性の高いデータ共有を可能にする分散型の不変の台帳を提供します。このユニークな機能は、患者記録、保険請求、臨床試験、サプライチェーンのデータが一般的にサイロ化され、照合が困難な環境では特に重要です。改ざん防止された情報へのリアルタイムアクセスを可能にするブロックチェーンは、データの完全性を高め、従来はシームレスな統合ができなかったシステム間の相互運用性を促進します。電子カルテ（EHR）の取り扱いにおけるサイバーセキュリティとプライバシーのニーズの高まりも大きな推進力となっており、ブロックチェーンは現在の基準を上回るエンドツーエンドの暗号化と検証可能なアクセス制御を提供します。遠隔医療、ウェアラブル、健康アプリによってデジタル医療サービスが成長する中、ブロックチェーンは、デバイス間で生成・共有されるセンシティブな健康データの急増を管理するソリューションを提示しています。さらに、政府や規制機関はこの技術の可能性をますます認識するようになっており、医療記録管理、薬剤トレーサビリティ、同意処理におけるブロックチェーンベースのアプリケーションをテストするためのパイロットプログラムや官民パートナーシップが世界的にいくつか開始されています。信頼性と透明性がヘルスケアの変革において重要な柱となる中、ブロックチェーンは単なるITの強化ではなく、ヘルスケア提供の新時代の基盤となるイネーブラーとして位置づけられています。

さまざまなヘルスケア・セグメントでブロックチェーン・アプリケーションはどのように進化しているのか？

ヘルスケアにおけるブロックチェーンの適用範囲は急速に拡大しており、患者データ管理、医薬品サプライチェーン、臨床試験、保険、医療提供者の資格認定など、複数のセグメントにまたがるアプリケーションが登場しています。患者記録の領域では、ブロックチェーンは、患者が所有し、管理し、複数のプロバイダーと安全に共有できる縦断的な健康記録の作成を促進します。これは慢性疾患の管理や、専門分野や地域を超えたケアの調整において特に価値があります。製薬業界では、製造元から薬局までの薬のエンド・ツー・エンドのトレーサビリティを可能にすることで、偽造薬対策にブロックチェーンが導入されています。このような透明性は、真正性を確保し、不正を減らし、医薬品回収の効率を高める。同様に、ブロックチェーンはプロトコール、患者の同意、試験結果に不変のタイムスタンプデータを提供することで、臨床試験の完全性を向上させています。保険業界では、スマートコントラクトが保険金請求の裁定を合理化し、承認と支払いを自動化すると同時に、不正行為と管理コストを削減しています。一方、ヘルスケア機関では、ブロックチェーンを利用してプロバイダーの資格や免許をリアルタイムで検証し、雇用を迅速化し、労働力の流動性を向上させる取り組みが始まっています。これらのアプリケーションは効率性を向上させるだけでなく、ヘルスケアのエコシステム全体で信頼がどのように構築され、維持されるかを再構築しています。相互運用可能なブロックチェーンプラットフォームを採用する医療機関が増えるにつれ、このテクノロジーはニッチな使用事例から企業全体の統合へと進化し、より協力的で患者中心、そしてデータセキュリティの高い未来を予告しています。

規制フレームワークと業界連携はブロックチェーン導入にどう影響するか？

ヘルスケアにおけるブロックチェーンの採用は、規制の枠組み、セクターを超えたコラボレーション、相互運用性と信頼を可能にする技術標準の確立に深く影響されます。規制の厳しい業界であるヘルスケアでは、ブロックチェーンの実装が米国のHIPAA、欧州のGDPR、その他の地域のデータ保護法などの厳しい法的要件に準拠していることを確認する必要があります。このような規制を遵守するためには、プライバシー・バイ・デザイン、選択的なデータ・アクセス、忘れられる権利などの機能をサポートできるブロックチェーン・アーキテクチャを慎重に設計する必要があります。このような複雑性を克服するために、シナプティック・ヘルス・アライアンスやメディレジャー・プロジェクトのような業界コンソーシアムが台頭しており、保険会社、プロバイダー、テクノロジー企業、規制機関が集まって、イノベーションを最大化しながらコンプライアンス基準を満たすブロックチェーンフレームワークを共同開発しています。また、データ交換やシステムの相互運用性のための共通プロトコルを作成する上でも、大規模展開の重要な障壁となっているコラボレーションが不可欠です。HL7やIEEEのような標準開発組織は、FHIR（Fast Healthcare Interoperability Resources）のような既存のヘルスケア相互運用性フレームワークへのブロックチェーンの組み込みに取り組んでいます。政府の資金援助やサンドボックス構想は、ヘルスケアにおけるブロックチェーンの実験をさらに加速させ、リスクの軽減やROIの検証に役立っています。競合の垣根を越えて利害関係者が一丸となって取り組むことができるかどうかが、ブロックチェーンがパイロットから普及にどれだけ早く移行できるかを大きく左右します。このような状況において、規制の明確化、利害関係者の連携、拡張性のある技術標準は、ヘルスケア業務の主流へのブロックチェーン統合のペースと範囲を形成する重要なイネーブラーになりつつあります。

ヘルスケアにおけるブロックチェーン市場の成長を促す主な要因とは？

ヘルスケアにおけるブロックチェーン市場の成長は、技術の進歩、業界の優先事項の変化、データの透明性とセキュリティに対する需要の高まりに根ざしたいくつかの要因によってもたらされています。何よりもまず、EHRや遠隔モニタリング機器からゲノム・データベースに至るまで、デジタル・ヘルス・データが爆発的に増加しているため、保存、共有、アクセス管理のための堅牢で改ざん防止されたシステムが必要とされています。第二に、データ漏洩や医療詐欺の増加により、医療機関は従来のITインフラに代わるより安全なものを求めており、ブロックチェーンはリアルタイムの追跡と、監査可能性と信頼性を高める暗号化セーフガードを提供しています。さらに、複数医療機関によるケアコーディネーション、遠隔医療の拡大、世界サプライチェーンに代表されるヘルスケア提供の複雑化に伴い、ブロックチェーンが可能にするデータ管理への分散型アプローチが求められています。例えば製薬会社は、特に世界なサプライチェーンの混乱を受け、医薬品の製造と流通における透明性とトレーサビリティを確保するためにブロックチェーンの採用を増やしています。また、価値観に基づく医療や患者中心のモデルへのシフトも大きな推進力となっており、透明性の高いデータの流れや検証可能な患者の転帰が求められています。ブロックチェーン・ヘルスケアの新興企業に対するベンチャーキャピタルの投資や企業の研究開発も、特に米国、欧州、アジア太平洋などの市場でイノベーションと展開を加速させています。最後に、患者の期待は進化しており、より多くの個人が自分の健康情報とその使用方法に対するコントロールを要求しているため、医療提供者と支払者は患者の主体性を高めるソリューションの導入を促しています。これらの要因が相まって、ブロックチェーン技術がヘルスケアに根付き、より安全で効率的な、信頼に基づくシステムへと変貌を遂げるための肥沃な環境が整いつつあります。

セグメント

ネットワーク（非公開ネットワーク、公開ネットワーク）、最終用途（バイオ医薬品・医療機器会社、プロバイダー、支払者）、アプリケーション（サプライチェーン管理アプリケーション、臨床試験アプリケーション、臨床データ交換アプリケーション）

調査対象企業の例（注目の36社）

  • Accenture Plc
  • Akiri
  • Avaneer Health
  • Blockchain Labs
  • Briya
  • BurstIQ
  • Change Healthcare
  • Chronicled
  • Doc.ai
  • Embleema
  • EncrypGen
  • FarmaTrust
  • Gem
  • Guardtime
  • IBM Corporation
  • iSolve LLC
  • Medicalchain
  • Microsoft Corporation
  • Nebula Genomics
  • Patientory Inc.

AIインテグレーション

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP36398

Global Blockchain in Healthcare Market to Reach US$13.0 Billion by 2030

The global market for Blockchain in Healthcare estimated at US$1.2 Billion in the year 2024, is expected to reach US$13.0 Billion by 2030, growing at a CAGR of 49.0% over the analysis period 2024-2030. Private Network, one of the segments analyzed in the report, is expected to record a 51.8% CAGR and reach US$10.4 Billion by the end of the analysis period. Growth in the Public Network segment is estimated at 40.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$312.2 Million While China is Forecast to Grow at 46.2% CAGR

The Blockchain in Healthcare market in the U.S. is estimated at US$312.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 46.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 44.9% and 41.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 33.2% CAGR.

Global Blockchain in Healthcare Market - Key Trends & Drivers Summarized

Why Is Blockchain Emerging as a Foundational Technology in Healthcare Innovation?

Blockchain technology is rapidly being embraced as a transformative force in healthcare, promising to address some of the most persistent challenges in the industry such as data fragmentation, security vulnerabilities, and inefficiencies in administrative processes. At its core, blockchain provides a decentralized, immutable ledger that enables secure and transparent data sharing across diverse healthcare stakeholders. This unique capability is particularly important in an environment where patient records, insurance claims, clinical trials, and supply chain data are typically siloed and difficult to reconcile. By enabling real-time access to tamper-proof information, blockchain enhances data integrity and facilitates interoperability between systems that traditionally have lacked seamless integration. The heightened need for cybersecurity and privacy in handling electronic health records (EHRs) is another major driver, with blockchain offering end-to-end encryption and verifiable access control that exceed current standards. As digital health services grow-driven by telemedicine, wearables, and health apps-blockchain presents a solution for managing the surge in sensitive health data being generated and shared across devices. Moreover, governments and regulatory bodies are increasingly recognizing the technology’s potential, with several pilot programs and public-private partnerships being launched globally to test blockchain-based applications in health record management, drug traceability, and consent handling. As trust and transparency become critical pillars in healthcare transformation, blockchain is positioning itself not merely as an IT enhancement but as a foundational enabler of a new era in healthcare delivery.

How Are Blockchain Applications Evolving Across Different Healthcare Segments?

The scope of blockchain in healthcare is expanding rapidly, with applications emerging across multiple segments including patient data management, pharmaceutical supply chains, clinical trials, insurance, and provider credentialing. In the realm of patient records, blockchain facilitates the creation of longitudinal health records that patients can own, control, and share securely with multiple providers. This is particularly valuable in managing chronic diseases and coordinating care across specialties and geographic regions. In the pharmaceutical industry, blockchain is being deployed to combat counterfeit drugs by enabling end-to-end traceability of medications from manufacturer to pharmacy. Such transparency ensures authenticity, reduces fraud, and enhances drug recall efficiency. Similarly, blockchain is improving the integrity of clinical trials by providing immutable timestamped data for protocols, patient consent, and trial results-ensuring regulatory compliance and minimizing the risk of data manipulation. In insurance, smart contracts are streamlining claims adjudication, automating approvals and payments while reducing fraud and administrative costs. Meanwhile, healthcare organizations are beginning to use blockchain to validate provider credentials and licensure in real-time, speeding up hiring and improving workforce mobility. These applications are not only improving efficiency but are also reshaping how trust is built and maintained across the healthcare ecosystem. As more healthcare entities adopt interoperable blockchain platforms, the technology is evolving from niche use cases to enterprise-wide integration, heralding a more collaborative, patient-centric, and data-secure future.

How Do Regulatory Frameworks and Industry Collaboration Influence Blockchain Adoption?

The adoption of blockchain in healthcare is deeply influenced by regulatory frameworks, cross-sector collaboration, and the establishment of technical standards that enable interoperability and trust. As a highly regulated industry, healthcare must ensure that blockchain implementations comply with strict legal requirements such as HIPAA in the U.S., GDPR in Europe, and other regional data protection laws. These regulations necessitate careful design of blockchain architectures that can support privacy by design, selective data access, and right-to-be-forgotten functionalities-capabilities that challenge the traditionally immutable nature of blockchain. To navigate these complexities, industry consortia such as the Synaptic Health Alliance and the MediLedger Project are emerging, bringing together insurers, providers, technology firms, and regulatory bodies to co-develop blockchain frameworks that meet compliance standards while maximizing innovation. Collaboration is also essential in creating common protocols for data exchange and system interoperability, which remain key barriers to large-scale deployment. Standards development organizations like HL7 and IEEE are working on incorporating blockchain into existing healthcare interoperability frameworks such as FHIR (Fast Healthcare Interoperability Resources). Government funding and sandbox initiatives are further accelerating blockchain experimentation in healthcare, helping mitigate risk and validate ROI. The ability of stakeholders to work collectively-across competitive boundaries-will largely determine how quickly blockchain can move from pilots to widespread adoption. In this context, regulatory clarity, stakeholder alignment, and scalable technical standards are becoming critical enablers that will shape the pace and scope of blockchain integration into mainstream healthcare operations.

What Key Factors Are Driving Growth in the Blockchain in Healthcare Market?

The growth in the blockchain in healthcare market is driven by several factors rooted in technology advancements, shifting industry priorities, and growing demand for data transparency and security. First and foremost, the explosion of digital health data-from EHRs and remote monitoring devices to genomic databases-requires robust, tamper-proof systems for storage, sharing, and access management, a need that blockchain is uniquely positioned to fulfill. Second, the rising incidence of data breaches and healthcare fraud is pushing institutions to seek more secure alternatives to traditional IT infrastructure, with blockchain offering real-time tracking and cryptographic safeguards that enhance auditability and trust. Additionally, the growing complexity of healthcare delivery-marked by multi-provider care coordination, telemedicine expansion, and global supply chains-demands a decentralized approach to data management that blockchain enables. Pharmaceutical companies, for example, are increasingly adopting blockchain to ensure transparency and traceability in drug manufacturing and distribution, especially in the wake of global supply chain disruptions. Another significant driver is the shift toward value-based care and patient-centric models, which require transparent data flows and verifiable patient outcomes-functions that blockchain can support through smart contracts and immutable patient records. Venture capital investment and corporate R&D in blockchain healthcare startups are also accelerating innovation and deployment, particularly in markets such as the U.S., Europe, and Asia-Pacific. Finally, patient expectations are evolving, with more individuals demanding control over their health information and how it is used, prompting providers and payers to adopt solutions that empower patient agency. Together, these factors are creating a fertile environment for blockchain technologies to take root in healthcare, transforming it into a more secure, efficient, and trust-based system.

SCOPE OF STUDY:

The report analyzes the Blockchain in Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Network (Private Network, Public Network); End-Use (Biopharma & Medical Device Companies End-Use, Providers End-Use, Payers End-Use); Application (Supply Chain Management Application, Clinical Trials Application, Clinical Data Exchange Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • Accenture Plc
  • Akiri
  • Avaneer Health
  • Blockchain Labs
  • Briya
  • BurstIQ
  • Change Healthcare
  • Chronicled
  • Doc.ai
  • Embleema
  • EncrypGen
  • FarmaTrust
  • Gem
  • Guardtime
  • IBM Corporation
  • iSolve LLC
  • Medicalchain
  • Microsoft Corporation
  • Nebula Genomics
  • Patientory Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Blockchain in Healthcare - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Focus on Data Security and Patient Privacy Throws the Spotlight on Blockchain Solutions in Healthcare
    • Rising Incidence of Cyberattacks Spurs Demand for Immutable and Decentralized Record-Keeping Systems
    • Here's How Blockchain Is Reshaping Electronic Health Record Sharing Across Multi-Stakeholder Networks
    • Push for Interoperability and Real-Time Access Fuels Blockchain Adoption in Health Information Exchange
    • Here's the Story: How Smart Contracts Are Streamlining Provider Payments and Clinical Trial Agreements
    • Growth in Digital Health Ecosystems Supports Blockchain-Based Identity and Consent Management Tools
    • Cross-Border Health Data Transfer and Medical Tourism Drive Demand for Blockchain-Enabled Credentialing
    • Public Health and Pandemic Response Platforms Explore Blockchain for Secure and Verified Data Sharing
    • Investment from Tech Giants and Startups Accelerates Innovation in Blockchain Healthcare Infrastructure
    • Lack of Technical Standards, Interoperability, and Industry Alignment Pose Adoption Challenges
    • Blockchain Integration with AI and IoMT Enhances Predictive Healthcare and Remote Monitoring Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Blockchain in Healthcare Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Blockchain in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Blockchain in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Blockchain in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Private Network by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Private Network by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Private Network by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Public Network by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Public Network by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Public Network by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Biopharma & Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Biopharma & Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Biopharma & Medical Device Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Providers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Payers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Supply Chain Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Supply Chain Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Supply Chain Management Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinical Trials Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Clinical Trials Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Clinical Trials Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinical Data Exchange Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinical Data Exchange Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Clinical Data Exchange Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • JAPAN
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • CHINA
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: China 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: China 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: China 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • EUROPE
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Blockchain in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Blockchain in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • FRANCE
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: France 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: France 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: France 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • GERMANY
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • REST OF WORLD
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of World 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030

IV. COMPETITION